Caffeic acid phenethyl ester decreases the level of S-100B protein after middle cerebral after occlusion in rabbits

Pakistan Journal of Pharmaceutical Sciences

Volumn 22, Issue 3, 2009, Pages 313-316

  Serarslan, Yurdal ^a,c   Bal, Ramazan ^b   Altuǧ, Muhammed Enes ^a   Kontaş, Tünay ^a   Melek, Ismet Murat ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b FIRAT UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Brain; Caffeic acid phenethyl ester; CAPE; Experimental stroke; MCA; Middle cerebral artery occlusion; S100B

Indexed keywords

CAFFEIC ACID PHENETHYL ESTER; PROTEIN S100B; BIOLOGICAL MARKER; CAFFEIC ACID DERIVATIVE; DRUG DERIVATIVE; NERVE GROWTH FACTOR; NEUROPROTECTIVE AGENT; PHENETHYL ALCOHOL; PROTEIN S 100; S 100 CALCIUM BINDING PROTEIN BETA SUBUNIT; S-100 CALCIUM-BINDING PROTEIN BETA SUBUNIT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; BRAIN DAMAGE; CONTROLLED STUDY; DRUG EFFICACY; MALE; MICROSURGERY; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROPROTECTION; NONHUMAN; PROTEIN BLOOD LEVEL; RABBIT; ANIMAL; BLOOD; CEREBRAL ARTERY DISEASE; CHRONIC BRAIN DISEASE; INTRAPERITONEAL DRUG ADMINISTRATION; METABOLISM;

ANIMALS; BIOLOGICAL MARKERS; BRAIN DAMAGE, CHRONIC; CAFFEIC ACIDS; INFARCTION, MIDDLE CEREBRAL ARTERY; INJECTIONS, INTRAPERITONEAL; MALE; NERVE GROWTH FACTORS; NEUROPROTECTIVE AGENTS; PHENYLETHYL ALCOHOL; RABBITS; S100 PROTEINS;

EID: 68549110519     PISSN: 1011601X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Altuǧ ME, Serarslan Y, Bal R, Kontaş T, Ekici F, Melek IM, Aslan H and Duman T (2008). Caffeic Acid Phenethyl Ester Protects Rabbit Brains Against Permanent Focal Ischemia By Antioxidant Action: A Biochemical And Planimetric Study. Brain Res., 1201: 135-142.
2. Bizzozero OA, Reyes S, Ziegler J and Smerjac S (2007). Lipid Peroxidation Scavengers Prevent the Carbonylation of Cytoskeletal Brain Proteins Induced by Glutathione Depletion. Neurochem. Res., 32: 2114-2122. (Pubitemid 350059855)
3. Buttner T, Weyers S, Postert T, Sprengelmeyer R and Kuhn W (1997). S-100 protein: serum marker of focal brain damage after ischemic territorial MCA infarction. Stroke, 28: 1961-1965. (Pubitemid 27459004)
4. Donato R (1991). Perspectives in S-100 protein biology. Cell Calcium., 12: 713-726.
5. Guide for the Care and Use of Laboratory Animals (1996). NIH Publication No.85-23, revised, New York.
6. Hardemark HG, Ericsson N, Kotwica Z, Rundström G, Mendel-Hartvig I, Olsson Y, Pahlman S and Persson L (1989). S-100 protein and neuron-specific enolase in CSF after experimental traumatic or focal ischemic brain damage. J. Neurosurg., 71: 727-731. (Pubitemid 19275772)
7. Hauschild A, Engel G, Brenner W, Gläser R, Mönig H, Henze E and Christophers E (1999). S100B protein detection in serum is a significant prognostic factor in metastatic melanoma. Oncology, 56: 338-344. (Pubitemid 29240361)
8. Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M and Gozukara ME (2003) Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell. Biochem. Funct., 21: 283-289. (Pubitemid 36988383)
9. Khayyal MT, el-Ghazaly MA and el-Khatib AS (1993). Mechanisms involved in the antiinflammatory effect of propolis extract. Drugs Exp. Clin. Res., 19: 197-203.
10. Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJ and van Engelen BG (2003). Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients. Brain Res. Bull., 61: 261-264. (Pubitemid 36952472)
11. Ma Z, Wei X, Fontanilla C, Noelker C, Dodel R, Hampel H and Du Y (2006). Caffeic acid phenethyl ester blocks free radical generation and 6-hydroxydopamine-induced neurotoxicity. Life Sci., 79: 1307-1311. (Pubitemid 44188796)
12. Martens P, Raabe A and Johnsson P (1998). Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia. Stroke, 29: 2363-2366. (Pubitemid 28511959)
13. Natarajan K, Gingh S, Burke TR, Grunberger D and Aggrawal BB (1996). Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription NF-κ B. Proc. Natl. Acad. Sci. USA, 93: 9090-9095. (Pubitemid 26282023)
14. Orban Z, Mitsiades N, Burke TR Jr, Tsokos M and Chrousos GP (2000). Caffeic acid phenethyl ester induces leukocyte apoptosis, modulates nuclear factor-kappa B and suppresses acute inflammation. Neuroimmunomodulation, 7: 99-105. (Pubitemid 30117304)
15. Pascual C, Gonzalez R and Torricella RG (1994). Scavenging action of propolis extract against oxygen radicals. J. Ethnopharmacol., 41: 9-13. (Pubitemid 24053224)
16. Raabe A, Menon DK, Gupta S, Czosnyka M and Pickard JD (1998). Jugular venous and arterial concentrations of serum S-100B protein in patients with severe head injury: a pilot study. J. Neurol. Neurosurg. Psychiatry, 65: 930-932. (Pubitemid 128710439)
17. Serarslan G, Altuǧ E, Kontas T, Atik E and Avci G (2007). Caffeic acid phenethyl ester accelerates cutaneous wound healing in a rat model and decreases oxidative stress. Clin. Exp. Dermatol., 32: 709-715. (Pubitemid 47610618)
18. Shirasaki Y, Edo N and Sato T (2004). Serum S-100b protein as a biomarker for the assessment of neuroprotectants. Brain Res., 1021: 159-166. (Pubitemid 39165792)
19. Tsai SK, Lin MJ, Liao PH, Yang CY, Lin SM, Liu SM, Lin RH, Chih CL and Huang SS (2006). Caffeic acid phenethyl ester ameliorates cerebral infarction in rats subjected to focal cerebral ischemia. Life Sci., 78: 2758-2762.
20. Yamamoto K, Yoshimine T and Yanagihara T (1985). Cerebral ischemia in rabbit: A new experimental model with immunohistochemical investigation. J. Cereb. Blood. Flow. Metab., 5: 529-536. (Pubitemid 16218227)